AI brief of an SEC Form 8-K · Corcept Therapeutics (CORT)

Corcept Therapeutics signs Redwood City sublease covering about 50,632 square feet

Neutral Impact 2 of 5 product/contract Written later

Corcept Therapeutics entered into a sublease on April 12, 2024 for about 50,632 rentable square feet at 101 Redwood Shores Parkway in Redwood City, California, with the sublessor Zuora, Inc. The lease runs from about July 1, 2024 through June 30, 2030, creating a new direct financial obligation. The filing discloses base rent averaging $1.4 million a year plus $240,000 a year for shared amenities, a modest commitment that the filing does not compare with Corcept's financial results.

Key points

  • Sublease dated April 12, 2024 with Zuora, Inc. for about 50,632 rentable square feet
  • Term expected to start on or around July 1, 2024 and end June 30, 2030
  • Base rent averages $1.4 million annually, plus $240,000 annually for shared amenities space
  • Full sublease to be filed with a Form 10-Q; Corcept intends to seek confidential treatment for some terms

The filing

CompanyCorcept Therapeutics (CORT)
Form8-K, current report
Filed with the SECApr 17, 2024, 6:05 AM ET
Accession number0001193125-24-098492

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 17, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.